Crossref

1. The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma

- Hao Zhang

- Renzheng Liu

- Lin Sun

- Weidong Guo

- Xiao Hu

- Alessandro Granito

2. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma

- Torsten Diesinger

- Alfred Lautwein

- Sebastian Bergler

- Dominik Buckert

- Christian Renz

- Radovan Dvorsky

- Vyacheslav Buko

- Siarhei Kirko

- Edith Schneider

- Florian Kuchenbauer

- Mukesh Kumar

- Cagatay Günes

- Felicitas Genze

- Berthold Büchele

- Thomas Simmet

- Martin Haslbeck

- Kai Masur

- Thomas Barth

- Dieter Müller-Enoch

- Thomas Wirth

- Thomas Haehner

- Alessandro Granito

3. Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer

- Feng Ju

- Kaixia Chen

- Dengyang Yin

4. Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo

- Chia-Hung Lin

- Ching-Yao Chang

- Kuan-Rong Lee

- Hui-Ju Lin

- Wu-Chou Lin

- Ter-Hsin Chen

- Lei Wan

5. Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma

- Dongyu Wu

- Guangcong Zhang

- Jiamei Ma

- Hongfen Wu

- Ju Xiong

- Xiaoxi Huang

- Yuanyuan Tian

- Taozhi Deng

- Xiangyang Han

- Xiaoning Sun

- Tian Xiang

- Xiangnan Yu

- Xuemei Jiang

- Alessandro Granito

6. Immunotherapy in hepatocellular carcinoma

- Luigi Buonaguro

- Angela Mauriello

- Beatrice Cavalluzzo

- Annacarmen Petrizzo

- Maria Tagliamonte

7. An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review

- Amit Kumar

- Ankit Siwach

- Prabhakar Verma

8. Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure

- Alessandro Granito

- Sara Marinelli

- Eleonora Terzi

- Fabio Piscaglia

- Matteo Renzulli

- Laura Venerandi

- Francesca Benevento

- Luigi Bolondi

9. Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation

- Renguo Guan

- Jie Mei

- Rongping Guo

10. RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma

- Yue Li

- Xiaoqin He

- Xiaoyu Zhang

- Yangtao Xu

- Wenliang Chen

- Xin Liu

- Ximing Xu

11. Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience

- Amr Shaaban Hanafy

12. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine

- Zainul Abedin Kapacee

- Mairéad G. McNamara

- Nicola de Liguori Carino

- Angela Lamarca

- Juan W. Valle

- Richard A. Hubner

13. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma

- Bowen Li

- Shibo Wei

- Liang Yang

- Xueqiang Peng

- Yingbo Ma

- Bo Wu

- Qing Fan

- Shuo Yang

- Xinyu Li

- Hongyuan Jin

- Shilei Tang

- Mingyao Huang

- Hangyu Li

- Jingang Liu

14. Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma

- Tin-Yun Tang

- Katherine Daunov

- Richard T. Lee

15. Potentiating cancer vaccine efficacy in liver cancer

- Maria Tagliamonte

- Annacarmen Petrizzo

- Angela Mauriello

- Maria Lina Tornesello

- Franco M Buonaguro

- Luigi Buonaguro

16. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma

- Jihan Wang

- Yangyang Wang

- Jing Xu

- Qiying Song

- Jingbo Shangguan

- Mengju Xue

- Hanghui Wang

- Jingyi Gan

- Wenjie Gao

17. Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation

- Franco Trevisani

- Giovanni Brandi

- Francesca Garuti

- Maria Aurelia Barbera

- Raffaella Tortora

- Andrea Casadei Gardini

- Alessandro Granito

- Francesco Tovoli

- Stefania De Lorenzo

- Andrea Lorenzo Inghilesi

- Francesco Giuseppe Foschi

- Mauro Bernardi

- Fabio Marra

- Rodolfo Sacco

- Giovan Giuseppe Di Costanzo

18. Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma

- Wei Sun

- Yongchao Zhang

- Bozhi Liu

- Youjia Duan

- Wei Li

- Jinglong Chen

- Alessandro Granito

19. Systemic treatments for hepatocellular carcinoma: challenges and future perspectives

- Francesco Tovoli

- Giulia Negrini

- Francesca Benevento

- Chiara Faggiano

- Elisabetta Goio

- Alessandro Granito

20.

21. Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma

- Jianrong Zheng

- Liao Zeng

- Mingqing Tang

- Hongjun Lin

- Chao Pi

- Ruian Xu

- Xiuling Cui

22. Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology

- Linda Beenet

23. Distribution of Breast Density in Iranian Women and its Association with Breast Cancer Risk Factors

- Nasrin Ahmadinejad

- Sajjadeh Movahedinia

- Samaneh Movahedinia

- Kourosh Holakouie Naieni

- Saharnaz Nejat

24. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma

- Guanghao Li

- Yongheng Liu

- Yanting Zhang

- Yao Xu

- Jin Zhang

- Xianfu Wei

- Zhongmin Zhang

- Chao Zhang

- Jinyan Feng

- Qiang Li

- Guowen Wang

25. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells

- Changjiang Lei

- Defa Ren

- Meixia Fu

- Chuantao Sun

- Hong Ren

- Qingyun Pan

- Yuan Li

26. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine

- Markus Wilhelmi

27. Combinatorial immunotherapy strategies for hepatocellular carcinoma

- Maria Tagliamonte

- Annacarmen Petrizzo

- Maria Lina Tornesello

- Gennaro Ciliberto

- Franco M Buonaguro

- Luigi Buonaguro

28. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis

- Hiroyuki Abe

- Kenya Kamimura

- Shujiro Okuda

- Yu Watanabe

- Jun Inoue

- Yutaka Aoyagi

- Toshifumi Wakai

- Ryo Kominami

- Shuji Terai

29. Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

- Nandini Gupta

- Neelkant Verma

- Bhoomika Patel